10mg | Tablets
A positive reimbursement decision was made on August 7 2019. Therefore, Fampyra® will be reimbursed from the 1st of September 2019, provided that patients meet a number of conditions. You can find these conditions on the website of the Dutch Zorg Instituut: Read more.
For Fampyra patients who have been eligible for the reimbursement scheme, it means that they must participate in a trial treatment via their neurologist within a year. Regardless of the result, Fampyra will be fully reimbursed by the health insurer up to the result of the trial treatment.
Now that a positive reimbursement decision has been made, the Reimbursement Scheme has been terminated as of the 1st of September 2019. The portion of the list price that came for patients at their own expense between January and August 2019 has been reimbursed retroactively.
Fampyra® is fully reimbursed since the 1st of September 2019. Therefore, the Reimbursement Scheme is ended on August 31, 2019. Claims with a dispense date from the 1st of January 2019 until 31 August 2019 could be submitted until October 31, 2019.
During the term of the Reimbursement Scheme, patients have paid a part of the list price by themselves. The amount of the list price that was paid by the patients themselves between January 2019 and August 2019, has been paid out retroactively.
Please note: this is the list price, the costs for VAT and service costs of the pharmacy are not reimbursed.
Quickly check the maximum contribution you have to pay for your medicine